Timothy J. Scannell, Director at NovoCure Ltd (NVCR), sold 999 shares at $17.32 ($17K) on 2025-06-03, disclosed to the SEC on 2025-06-04.
Open-market sale of $17k NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PODD | SELL | 2024-06-11 | $1.3M | — | Filing → |
| NVCR | SELL | 2024-06-06 | $23K | — | Filing → |
| PODD | SELL | 2024-05-29 | $597K | — | Filing → |